Pharmacotherapy to gene editing: potential therapeutic approaches for Hutchinson–Gilford progeria syndrome
- 11 February 2020
- journal article
- review article
- Published by Springer Nature in GeroScience
- Vol. 42 (2) , 467-494
Abstract
Hutchinson–Gilford progeria syndrome (HGPS), commonly called progeria, is an extremely rare disorder that affects only one child per four million births. It is characterized by accelerated aging in affected individuals leading to premature death at an average age of 14.5 years due to cardiovascular complications. The main cause of HGPS is a sporadic autosomal dominant point mutation in LMNA gene resulting in differently spliced lamin A protein known as progerin. Accumulation of progerin under nuclear lamina and activation of its downstream effectors cause perturbation in cellular morphology and physiology which leads to a systemic disorder that mainly impairs the cardiovascular system, bones, skin, and overall growth. Till now, no cure has been found for this catastrophic disorder; however, several therapeutic strategies are under development. The current review focuses on the overall progress in the field of therapeutic approaches for the management/cure of HGPS. We have also discussed the new disease models that have been developed for the study of this rare disorder. Moreover, we have highlighted the therapeutic application of extracellular vesicles derived from stem cells against aging and aging-related disorders and, therefore, suggest the same for the treatment of HGPS.Keywords
This publication has 243 references indexed in Scilit:
- Otologic and audiologic manifestations of hutchinson‐gilford progeria syndromeThe Laryngoscope, 2011
- Targeted Gene Correction of Laminopathy-Associated LMNA Mutations in Patient-Specific iPSCsCell Stem Cell, 2011
- Recapitulation of premature ageing with iPSCs from Hutchinson–Gilford progeria syndromeNature, 2011
- Functional Coupling between the Extracellular Matrix and Nuclear Lamina by Wnt Signaling in ProgeriaDevelopmental Cell, 2010
- Mechanisms of Life Span Extension by Rapamycin in the Fruit Fly Drosophila melanogasterCell Metabolism, 2010
- Novel roles for A‐type lamins in telomere biology and the DNA damage response pathwayThe EMBO Journal, 2009
- The M‐type receptor PLA2R regulates senescence through the p53 pathwayEMBO Reports, 2009
- Lamin A-dependent misregulation of adult stem cells associated with accelerated ageingNature Cell Biology, 2008
- Treatment with a farnesyltransferase inhibitor improves survival in mice with a Hutchinson–Gilford progeria syndrome mutationBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2008
- Influence of TOR kinase on lifespan in C. elegansNature, 2003